Dermatological adverse events with taxane chemotherapy
…, H Roche, VR Belum, L Gladieff, M Deslandres… - European Journal of …, 2016 - Springer
Taxanes (docetaxel and paclitaxel) are among the most commonly prescribed anticancer
drugs approved for the treatment of metastatic or locally advanced breast, non-small cell lung, …
drugs approved for the treatment of metastatic or locally advanced breast, non-small cell lung, …
Incidence of venous thromboembolism in patients with newly diagnosed pancreatic cancer and factors associated with outcomes
…, B Suc, R Guimbaud, C Couteau, M Deslandres… - Gastroenterology, 2020 - Elsevier
Background & Aims Pancreatic ductal adenocarcinoma (PDAC) is associated with the highest
incidence of venous thromboembolism (VTE) of any cancer type. However, little is known …
incidence of venous thromboembolism (VTE) of any cancer type. However, little is known …
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer
…, AG Moreno, B Cabarrou, M Deslandres… - International Journal of …, 2022 - ijgc.bmj.com
Objective We sought to evaluate the impact of chemotherapy response score according to
the number of cycles of neoadjuvant chemotherapy, on disease-free survival and overall …
the number of cycles of neoadjuvant chemotherapy, on disease-free survival and overall …
Cervical cancer with paraaortic involvement: do patients truly benefit from tailored chemoradiation therapy? A retrospective study on 8 French centers
…, B Lepage, P Mathevet, M Deslandres… - European Journal of …, 2015 - Elsevier
We retrospectively studied the therapeutic significance of extended-field radiotherapy
combined with concurrent platinum-based chemotherapy for the management of cervical …
combined with concurrent platinum-based chemotherapy for the management of cervical …
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory …
J Bennouna, M Deslandres, H Senellart… - Investigational new …, 2015 - Springer
Background Pazopanib is a multi-targeted tyrosine kinase inhibitor shown to be clinically
active in the treatment of various cancer types. This study aimed to evaluate the maximum …
active in the treatment of various cancer types. This study aimed to evaluate the maximum …
18F-FDG PET/CT identifies predictors of survival in patients with locally advanced cervical carcinoma and paraaortic lymph node involvement to allow intensification of …
…, M Voglimacci, A Weyl, M Deslandres… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Our objective was to use 18 F-FDG PET/CT to identify a high-risk subgroup requiring
therapeutic intensification among patients with locally advanced cervical cancer (LACC) and …
therapeutic intensification among patients with locally advanced cervical cancer (LACC) and …
[HTML][HTML] Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33 …
…, L Montaigne, I Baumgaertner, M Deslandres… - BMC cancer, 2023 - Springer
Background In case of locally advanced and/or non-metastatic unresectable esophageal
cancer, definitive chemoradiotherapy (CRT) delivering 50 Gy in 25 daily fractions in …
cancer, definitive chemoradiotherapy (CRT) delivering 50 Gy in 25 daily fractions in …
[HTML][HTML] Outcomes of Different In Vitro Maturation Procedures for Oocyte Cryopreservation for Fertility Preservation and yet Another Live Birth in a Cancer Patient
…, C Fajau-Prevot, M Clouet, P Assouline, M Deslandres… - Life, 2023 - mdpi.com
To ensure patient care in an oncological fertility preservation (FP) programme, specialists
must provide technology that best suits the patients’ clinical conditions. In vitro oocyte …
must provide technology that best suits the patients’ clinical conditions. In vitro oocyte …
A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer
…, P Erbs, M Deslandres-Cruchant… - European journal of …, 2003 - academic.oup.com
Objective Mutations in the ligand-binding domain of the human androgen receptor (AR)
figure among the ways used by prostate adenocarcinoma (PCa) cells to escape androgen …
figure among the ways used by prostate adenocarcinoma (PCa) cells to escape androgen …
A phase I study of ixabepilone in combination with epirubicin in patients with metastatic breast cancer
…, S Govi, F Dalenc, A Locatelli, M Deslandres… - Clinical Breast …, 2012 - Elsevier
Purpose The objectives of this phase I trial were to determine the maximum-tolerated dose (MTD),
toxicity profile, dose-limiting toxicities (DLT), pharmacokinetics, and the recommended …
toxicity profile, dose-limiting toxicities (DLT), pharmacokinetics, and the recommended …